Page last updated: 2024-10-29

imipramine and Infections, Staphylococcal

imipramine has been researched along with Infections, Staphylococcal in 2 studies

Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Elsebaei, MM1
Mohammad, H1
Abouf, M1
Abutaleb, NS2
Hegazy, YA1
Ghiaty, A1
Chen, L1
Zhang, J1
Malwal, SR1
Oldfield, E1
Seleem, MN2
Mayhoub, AS2
Shahin, IG1
Alhashimi, M1
Kassab, AE1
Mohamed, KO1
Taher, AT1

Other Studies

2 other studies available for imipramine and Infections, Staphylococcal

ArticleYear
Alkynyl-containing phenylthiazoles: Systemically active antibacterial agents effective against methicillin-resistant Staphylococcus aureus (MRSA).
    European journal of medicinal chemistry, 2018, Mar-25, Volume: 148

    Topics: Alkynes; Animals; Anti-Bacterial Agents; Half-Life; Methicillin-Resistant Staphylococcus aureus; Mic

2018
Evaluation of N-phenyl-2-aminothiazoles for treatment of multi-drug resistant and intracellular Staphylococcus aureus infections.
    European journal of medicinal chemistry, 2020, Sep-15, Volume: 202

    Topics: Animals; Anti-Bacterial Agents; Cell Line; Cell Survival; Dose-Response Relationship, Drug; Humans;

2020